FOXO4 and osteosarcoma: In human OSA, a study by Chen and colleagues found that the oncogenic miRNA, miR-664, promoted cell proliferation by supressing FOXO4 expression, suggesting that FOXO4 has a role as a tumour suppressor in osteosarcoma [32].